Acute mesenteric, portal and inferior vena cava (IVC) venous thrombosis: optimal outcome achieved with anticoagulation by Alvi, Abdul Rehman et al.
eCommons@AKU
Department of Surgery Department of Surgery
May 2010
Acute mesenteric, portal and inferior vena cava
(IVC) venous thrombosis: optimal outcome
achieved with anticoagulation
Abdul Rehman Alvi
Aga Khan University, rehman.alvi@aku.edu
Shahida Bibi
Zia ur Rehman
Aga Khan University, ziaur.rehman@aku.edu
Sameullah Khan Niazi
Follow this and additional works at: https://ecommons.aku.edu/pakistan_fhs_mc_surg_surg
Part of the Surgery Commons
Recommended Citation
Alvi, A. R., Bibi, S., ur Rehman, Z., Niazi, S. K. (2010). Acute mesenteric, portal and inferior vena cava (IVC) venous thrombosis:
optimal outcome achieved with anticoagulation. Journal of Pakistan Medical Association, 60(5), 397-399.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_surg_surg/686
Abstract
The prevalence and clinical spectrum of acute
mesenteric venous thrombosis (AMVT) in Pakistan is largely
unknown. The authors report two patients with acute
mesenteric, portal and inferior vena cava venous thrombosis
confirmed on CT imaging. The diagnoses were established
within 24 hours of presentation and both patients were
successfully treated with therapeutic heparin during hospital
admission and continued on oral warfarin because of
hypercoagulable state. The protocol that we currently use is
evidence based and is leading to optimal outcome.
Introduction
Acute mesenteric Venous thrombosis (AMVT) is an
uncommon but potentially life threatening type of acute
mesenteric ischaemia but fortunately comprises 5-15% of all
causes.1,2 In 1895 Elliott first described the phenomenon of
acute mesenteric venous thrombosis and subsequently Abu et
al identified 375 cases of AMVT in international literature
since 1911-1984.2 In 22 years 72 cases were reported from
Mayo clinic (1972-1993) and this comprises 6.2% of all cases
of mesenteric ischaemia. The literature reported various
aspects of AMVT including probable etiology, presentation,
diagnostic modalities and therapeutics.2,3 The diagnosis of
MVT remained a serious challenge to the clinicians and was
often diagnosed on laparotomy with mortality of more than
34%.4Advancement in radiological imaging like the CT scan
have enabled the early detection of the disease and opened
new avenues in its management.3,4 Early diagnosis and better
understanding of the disease process have enabled the
clinicians to avert the consequences of AMVT by appropriate
anticoagulation and opened the door for non-operative
management.3
Case Report
The first case was of a 30 year old female who
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presented to the emergency room with complaints of central
abdominal pain, nausea and vomiting of 10 days duration.
The past history was unremarkable and there was no history
of oral or injectable contraceptives. She looked dehydrated
but was stable haemodynamically with heart rate of
100/minute, blood pressure of 120/80 mmHg and normal
core temperature. Abdomen was distended and tender on
deep palpation all over with increased tenderness in right
lower quadrant. However, no signs of peritonitis were
present. The initial laboratory investigation showed
haemoglobin of 11.8 gm/dl (normal range: 11.1-14.5) with
haematocrit of 35% (normal range: 35.4-42 %), white cell
count of 9.4 (normal range: 4.0-10) x10E9/L with 74.6%
neutrophils and platelet count of 426 (150-400) x10E9/L. Her
serum amylase, electrolytes, liver function tests, arterial
blood gas analysis and coagulation profiles were within
normal limits. Plain abdominal X-rays and ultra-sonography
were normal. Double contrast CT scan abdomen was done to
explain the out of proportion severe abdominal pain. CT scan
findings were suggestive of small bowel ischaemia secondary
to extensive thrombosis involving the entire superior
mesenteric vein, portal vein and partial thrombosis of inferior
vena cava was also demonstrated.
After initial fluid resuscitation, she was started on
therapeutic intravenous heparin therapy, with an initial
bolus of 10000 units followed by heparin infusion. The
heparin infusion was titrated to maintain the I.N.R in the
range of 2.5 to 3 ratios. She was monitored closely in the
high dependent unit and responded very well to
anticoagulation therapy, with a decrease in the intensity of
abdominal pain and tenderness. Patient was started on oral
anti coagulant (Tab.Warfarin) on third day of admission
when she was tolerating oral diet. She was discharged on
8th day of admission on therapeutic oral anti coagulant and
advised to regularly monitor the Prothrombin Time (PT)
and to keep INR in therapeutic range (2.5-3 ratio).
The serum anticoagulant factors profile was
available and showed protein-C of 60% (72-106); protein- S
of 5% (65-110), antithrombin III of 94% (80-120) and factor
V Leiden of 2.5% (1.75-2.80). On 6 months follow up she
remained asymptomatic, continued on oral warfarin, INR
was kept at 3 ratio. Patient was advised to continue life long
anticoagulant therapy.
The second patient was a 40 year old male who was in
his usual state of health until one week back when he
developed generalized abdominal pain, which gradually
increased in intensity and was associated with anorexia and
nausea. His past medical history was significant for deep
venous thrombosis of the left leg 18 months back and he was
on oral warfarin for a period 6 months prior to the current
condition. On clinical examination in the emergency room he
was found to be in severe abdominal pain but vital signs were
within normal limits. His abdomen was distended and tender
all over on deep palpation, however, no signs of peritonitis
were present. The initial laboratory investigation showed
haemoglobin of 12.8 gm/dl (normal range: 13.7-16.3) with
haematocrit of 37.7% (41.9-48.7), white cell count of 8.1
(normal range: 4.0-10) x10E9/L with neutrophils of 84%. His
serum electrolytes, liver function tests, serum amylase, lipase
and arterial blood gas analysis were within normal limits.
Abdominal ultrasonography and plain X-rays were normal.
The double contrast CT scan of the abdomen revealed
thrombosis of superior mesenteric vein, extensive thrombosis
of portal vein, thrombus in Interior Vena Cava (IVC), mild
ascites and thickned oedematous colon.
Patient was started on therapeutic intravenous heparin
infusion and was monitored closely in high dependent unit
with serial APTT and INR to keep these parameters within the
therapeutic range. He responded very well on anti coagulant
therapy, with decreased abdominal pain and tenderness. The
serum anticoagulant factors results were available and showed
protein-S of 10% (normal range: 65-110), protein-C of 56%
(normal range: 72-106), anti thrombin III 89% (normal range:
80-120), factor V Leiden of 2.02 (normal range: 1.75-2.80),
anticardiolipin IGG of 1.5, anticardiolipin IGM of 1.9 and
serum homocystein of 15.71 H (normal range: 4.45-12.42).
Patient was discharged on oral warfarin with the
advice to continue the drug life long. He remained
asymptomatic on 18 months follow up with no evidence of
recurrent, portal hypertension or bowel stricture.
Discussion
Acute mesenteric venous thrombosis is an uncommon
cause of mesenteric ischaemia with mortality rate of 34-40%
in early 1990.4 The high mortality was contributed to delay in
diagnosis established on exploratory laparotomy. These
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patients did not receive peri-operative anticoagulation therapy.
Improved understanding of disease process and availability of
CT scan changed the management of AMVT with increased
emphasis on early anticoagulation therapy and the desired
results were achieved in 15 patients with no mortality.5 A
study from China reported 44 patients with AMVT which
were divided into operative and non operative group. The
results showed 39 % mortality in operated and 11% in non
operated group. The authors proposed early anticoagulation
therapy to achieve the best outcome in AMVT.6A study from
India in 32 patients with AMVT further consolidated the
preference of early anticoagulation in all patients and surgical
treatment in cases of peritonitis achieved low mortality.7 A
retrospective review of 57 patients showed optimal outcome
with early diagnosis on CT scan and prompt anticoagulation
therapy.8 The operative intervention was required only in
clinical and radiological signs of bowel infarction and the
study did not uphold the mandatory second look laparotomy.
This case series and other reports10,11 show that the
number of patients with primary AMVT continues to decrease
with increased facilities to recognize hypercoagulable state.
An apparent increase of AMVT as we have experienced over
the past 7 years may be due to improved radiological imaging
like 64-sliced CT scan with high resolution angiography
facilities and this is also experienced by other centers.6-8
With high index of clinical suspicion in patients with
abdominal pain and liberal use of CT scanning, enabled us to
confirm the diagnosis of AMVT. Reports suggest that early
anticoagulant therapy improves outcome in both medical and
surgical treated patients.6-9 Both of the patients were
investigated for hypercoagulable state and were found to have
protein C and S deficiencies. There are reports of 60-70%
secondary AMVT and there is a suggestion to continue
lifelong anticoagulation therapy and hence avoid recurrence of
the disease.10,11
Our case series shows that non-operative therapy is an
option when the diagnosis is confirmed on CT imaging and
when the patient does not have peritonitis. Bowel ischaemia
due to AMVT is a reversible process with early anticoagulant
therapy.6-8 Prompt diagnosis has allowed us to manage the
patients non-operatively with optimal outcome, no mortality
and shorter hospital stay. With the protocol to continue oral
anticoagulant (Tab.Warfarin) for lifelong in secondary AMVT
has proven to be effective with no recurrence on follow up.
Conclusion
In conclusion, acute mesenteric venous thrombosis
must be kept in mind as a possible diagnosis with abdominal
pain out of proportion to physical findings. Early CT imaging
allows for immediate anticoagulation and seems to improve
outcome. Patients with AMVT should be screened for
hypercoagulable state and patients with secondary AMVT
should be on life long anticoagulant treatment to prevent
recurrence.
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